Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2013-01-16 Legal Proceedings Report
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage framgång i omprövningsförfarande
Legal Proceedings Report Classification · 99% confidence The document is a press release dated January 16, 2013, announcing a significant legal/regulatory outcome: the US Patent Office's appeals board invalidated all patent claims in a patent infringement case against Biotage AB. This directly concerns a significant lawsuit and regulatory action involving the company. This fits the definition of 'Legal Proceedings Report' (LTR) better than a general 'Regulatory Filing' (RNS), as it details the outcome of a specific legal matter (patent dispute). It is not an earnings release, annual report, or management discussion.
2013-01-16 Swedish
Biotage success in re-examination proceedings
Legal Proceedings Report Classification · 98% confidence The document is a press release dated January 16, 2013, detailing a legal victory for Biotage AB where the US Patent and Trademark Office's Patent Trial and Appeal Board affirmed the rejection of patent claims asserted against Biotage in a lawsuit filed by Scientific Plastic Products, Inc. (SPP). This content directly relates to significant litigation and regulatory/legal outcomes involving the company's intellectual property. This fits the definition of a Legal Proceedings Report (LTR), which covers updates on significant lawsuits or regulatory actions. It is not an earnings release (ER), a general regulatory filing (RNS), or a report publication announcement (RPA) as it contains substantive news, not just an announcement of another document's availability.
2013-01-16 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-September 2012. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance. It is clearly a substantive financial report for a period shorter than a full fiscal year, not an announcement or a summary, and exceeds the length requirements for a simple announcement. 9M 2012
2012-10-26 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January - September 2012' and contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary for the nine-month period. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report. 9M 2012
2012-10-26 English
Valberedning Biotage AB
Board/Management Information Classification · 99% confidence The document is a press release dated October 16, 2012, announcing the formation of a Nomination Committee (Valberedning) for Biotage AB ahead of the 2013 Annual General Meeting (Årsstämman). The committee's tasks include preparing the election of board members, chairman, auditors, and remuneration issues for the AGM. This content directly relates to the preparation and governance surrounding the Annual General Meeting, specifically concerning board nominations and related matters. This aligns best with the 'AGM Information' category (AGM-R), as it is preparatory material for the meeting, rather than a general governance report (CGR) or a proxy statement (PSI). Given the specific focus on the nomination committee for the upcoming AGM, AGM-R is the most precise fit.
2012-10-16 Swedish
Biotage AB Nomination Committee
Board/Management Information Classification · 99% confidence The document is a press release from Biotage AB dated October 16, 2012, announcing the formation of the Nomination Committee. This committee is tasked with preparing proposals for the election of the Board of Directors and related matters ahead of the Annual General Meeting (AGM) 2013. While it relates to the AGM, it is an announcement about the committee formation and process, not the AGM materials themselves (AGM-R) or the proxy solicitation (PSI). It is a specific corporate governance announcement regarding board nominations, which falls under the general scope of corporate governance practices, but more specifically relates to the process leading up to shareholder meetings and board composition. Given the options, this announcement about the composition and mandate of the Nomination Committee preparing for the AGM is best classified as Governance Information (CGR), as it details internal rules/structure related to board elections, or potentially Regulatory Filings (RNS) if CGR is too specific for a committee formation notice. However, since it directly concerns the structure and nomination process for the Board of Directors, CGR (Governance Information) is the most appropriate fit among the specific categories, as it details governance structure setup.
2012-10-16 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.